Oct. 3 at 4:18 PM
$CYCN Cyclerion likely licensed both MIT Case #25342P and Case #20652M. Case #25342P covers novel combinations of anesthetic agents for treating treatment-resistant depression, aligning with Cyclerion’s lead program and clinical trial plans; however, no public patents are currently available for this case, suggesting pending or confidential status. Case #20652M involves software and methods for controlling neural responses in deep brain regions, supporting the device and algorithmic system Cyclerion describes. This case has publicly available patents, including US 11,813,406 and US 12,311,113, which cover neural modulation technologies. Together, these cases provide a comprehensive IP package combining anesthetic therapy (25342P) with neural modulation technology (20652M). This dual license underpins Cyclerion’s integrated neuropsychiatric treatment approach, combining drug regimens with neuromodulation devices as reflected in their investor materials.
https://tlo.mit.edu/industry-entrepreneurs/available-technologies
